Community-Based Interventions for Infant Health in Nepal

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by Institute of Child Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Institute of Child Health
ClinicalTrials.gov Identifier:
NCT00656591
First received: December 22, 2006
Last updated: April 7, 2008
Last verified: April 2008
  Purpose

An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal & Infant Mortality and to Improve Fetal Growth & Cognitive Development in Infancy


Condition Intervention Phase
Child Mortality
Drug: Methotrexate
Phase 1

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal and Infant Mortality, and to Improve Fetal Growth and Cognitive Development in Infancy.

Resource links provided by NLM:


Further study details as provided by Institute of Child Health:

Primary Outcome Measures:
  • neonatal mortality rates [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 192000
Study Start Date: March 2005
Estimated Study Completion Date: December 2008
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Methotrexate
    Methotrexate
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

48 village development committee areas

Criteria

Inclusion Criteria:

  • mothers, community health volunteers

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00656591

Locations
United Kingdom
International Child Health, ICH Recruiting
London, United Kingdom, WC1N 1EH
Contact: Anthony Costello, Dr       a.costello@ich.ucl.ac.uk   
Sponsors and Collaborators
Institute of Child Health
Investigators
Principal Investigator: Anthony Costello, Dr Institute of Child Health
  More Information

No publications provided

Responsible Party: R&D Office, Institute of Child Health
ClinicalTrials.gov Identifier: NCT00656591     History of Changes
Other Study ID Numbers: 04PC01
Study First Received: December 22, 2006
Last Updated: April 7, 2008
Health Authority: United Kingdom: National Health Service
United Kingdom: Research Ethics Committee

Keywords provided by Institute of Child Health:
Child mortality, Nepal, Community, care practices

Additional relevant MeSH terms:
Methotrexate
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses
Antimetabolites, Antineoplastic
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunosuppressive Agents
Immunologic Factors
Antirheumatic Agents
Nucleic Acid Synthesis Inhibitors

ClinicalTrials.gov processed this record on April 22, 2014